Instrumentarium to Acquire Spacelabs Medical

(Redmond, WA, USA) for about US$140 million.

Spacelabs Medical supplies a full range of patient-monitoring products and information systems for use in hospitals. The company had sales of $242 million in 2001. In international sales to the critical care market, Spacelabs Medical will cooperate closely with Instrumentarium's Datex-Ohmeda division, a leading provider of critical care and anesthesia products. Both Datex-Ohmeda and Spacelabs Medical will continue to serve their respective distributors worldwide. Thus, the acquisition is not expected to have a significant effect on the global critical care operations of Datex-Ohmeda in markets outside the United States or the US operations of Datex-Ohmeda in anesthesia.

Instrumentarium had sales of $920 million in 2001, of which 70% was from anesthesia and critical care products. "Instrumentarium has achieved a leading position through Datex-Ohmeda in most of the world's critical care monitoring markets, and as a result of this acquisition, we now extend our leadership globally to also include the strategically important US market,” said Olli Riikkala, president and CEO of Instrumentarium.




Related Links:
Instrumentarium
Spacelabs